Helena Mörse

knuten till universitetet
Fler filtreringsmöjligheter
  1. 2019
  2. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment

    Anna Nyström, Helena Mörse, Hanna Nordlöf, Karin Wiebe, Maria Artman, Ingrid Øra, Aleksander Giwercman, Emir Henic & Maria Elfving, 2019, I : Acta Oncologica. 58, 2, s. 218-224

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2017
  4. Anti-Müllerian hormone as a marker of ovarian reserve in girls before, during and after treatment for childhood cancer

    Helena Mörse, 2017, Lund: Lund University: Faculty of Medicine.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  5. 2016
  6. Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma

    Helena Mörse, Maria Elfving, Aleksandra Turkiewicz, Claus Yding Andersen & Ingrid Øra, 2016 aug 1, I : Medicine. 95, 33, 2107.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2013
  8. Acute onset of ovarian dysfunction in young females after start of cancer treatment.

    Helena Mörse, Maria Elfving, Anna Lindgren, Pål Wölner-Hanssen, Claus Yding Andersen & Ingrid Øra, 2013, I : Pediatric Blood & Cancer. 60, 4, s. 676-681

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2006
  10. Complications of video-assisted gastrostomy in children with malignancies or neurological diseases.

    Einar Arnbjornsson, Torbjorn Backman, Helena Mörse, Yvonne Berglund, Carl-Magnus Kullendorff & Hakan Lovkvist, 2006, I : Acta Pædiatrica. 95, 4, s. 467-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2005
  12. Evidence for a single-step mechanism in the origin of hyperdiploid childhood acute lymphoblastic leukemia.

    Kajsa Paulsson, Helena Mörse, Thoas Fioretos, Mikael Behrendtz, Bodil Strömbeck & Bertil Johansson, 2005, I : Genes, Chromosomes and Cancer. 44, 2, s. 113-122

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations.

    Anna Andersson, Tor Olofsson, David Lindgren, Björn Nilsson, Cecilia Ritz, Patrik Edén, Carin Lassen, Johan Råde, Magnus Fontes, Helena Mörse, Jesper Heldrup, Mikael Behrendtz, Felix Mitelman, Mattias Höglund, Bertil Johansson & Thoas Fioretos, 2005, I : Proceedings of the National Academy of Sciences. 102, 52, s. 19069-19074

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2004
  15. MLL/GRAF fusion in an infant acute monocytic leukemia (AML M5b) with a cytogenetically cryptic ins(5;11)(q31;q23q23).

    Ioannis Panagopoulos, Ashly Kitagawa, Margareth Isaksson, Helena Mörse, Felix Mitelman & Bertil Johansson, 2004, I : Genes, Chromosomes and Cancer. 41, 4, s. 400-404

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2003
  17. Plasma neutrophil lipocalin, elastase-alpha1-antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome.

    Tomas Sveger, K Ohlsson, Helena Mörse, Staffan Polberger & Sven Laurin, 2003, I : Scandinavian Journal of Clinical & Laboratory Investigation. 63, 2, s. 89-92

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2002
  19. Tracheobronchial aspirate fluid neutrophil lipocalin, elastase- and neutrophil protease-4-alpha1-antitrypsin complexes, protease inhibitors and free proteolytic activity in respiratory distress syndrome.

    Tomas Sveger, K Ohlsson, Staffan Polberger, G Noack, Helena Mörse & Sven Laurin, 2002, I : Acta Pædiatrica. 91, 9, s. 934-937

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift